Claiborne Cary J 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed Nov 3, 2021
Insider Transaction Report
Form 4
Claiborne Cary J
DirectorChief Executive Officer
Transactions
- Award
Stock Option
2021-11-02+60,000→ 60,000 totalExercise: $3.15From: 2021-11-02Exp: 2031-11-01→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months.